Drug
Amg 510
Amg 510: highest development phase Phase 1/2, developed by Amgen. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1/2
- Developer
- Amgen
Trials
| Drug | Phase | Indication |
|---|---|---|
| AMG 510 NCT05180422 | Phase 1/2 | Non Small Cell Lung Cancer |
Latest
No recent events.
Follow Amg 510 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.